Actinium Pharmaceuticals Inc (STU:7AY1)
€ 1.213 -0.08 (-6.19%) Market Cap: 38.98 Mil Enterprise Value: -33.86 Mil PE Ratio: 0 PB Ratio: 1.14 GF Score: 29/100

Actinium Pharmaceuticals Inc at Benzinga Global Small Cap Conference (Virtual) Transcript

Oct 27, 2021 - Oct 28, 2021 / NTS GMT
Release Date Price: €6.6 (-2.22%)
Spencer Israel
Benzinga - Moderator

We have our next speaker. Yes, we have to see him in there. Let's get Steve O'Loughlin on. He's the CFO of Actinium Pharmaceuticals. There he is. Steve, how we doing today?

Steve O;Loughlin
Actinium Pharmaceuticals, Inc. - CFO

' -

Doing well. How are you?

Spencer Israel
Benzinga - Moderator

Doing well, doing well. Let me make sure we have your slides. Yes, we do. Let's get the slides up on the screen and I will turn it over, sir.

Steve O;Loughlin
Actinium Pharmaceuticals, Inc. - CFO

' -

Fantastic. Thank you very much, folks. It's great to be back. I appreciate the opportunity to provide an update on Actinium Pharmaceuticals' progress. Before I begin, just a disclaimer and Safe Harbor as I may be making forward-looking statements in today's presentation, which encourage everyone to reference our SEC filings as they may be updated and amended from time to time.

So Actinium is a company

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot